Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review

por Tziomalos, Konstantinos, Athyros, Vasilios G
Publicado 2006

Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters

por Athyros, Vasilios G, Mikhailidis, Dimitri P
Publicado 2012

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?

por Katsiki, Niki, Athyros, Vasilios G., Karagiannis, Asterios
Publicado 2013

Off target effects of statins shape total mortality?

por Athyros, Vasilios G., Katsiki, Niki, Karagiannis, Asterios
Publicado 2016

Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action

por Athyros, Vasilios Gabriel, Doumas, Michael, Karagiannis, Asterios
Publicado 2016

Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?

por Athyros, Vasilios G, Katsiki, Niki, Tziomalos, Konstantinos, Karagiannis, Asterios
Publicado 2011

Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment

por Athyros, Vasilios G, Tziomalos, Konstantinos, Karagiannis, Asterios, Mikhailidis, Dimitri P
Publicado 2011

Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases

por Tziomalos, Konstantinos, Athyros, Vasilios G, Karagiannis, Asterios, Mikhailidis, Dimitri P
Publicado 2011

Suboptimal management of dyslipidemia in everyday clinical practice: Alarming signals from real-world data

por Athyros, Vasilios G., Stavropoulos, Konstantinos, Imprialos, Konstantinos P., Doumas, Michael
Publicado 2020

Is There a Role for Hypolipidaemic Drug Therapy in the Prevention or Treatment of Microvascular Complications of Diabetes?

por Mitsiou, Eydoxia K, Athyros, Vasilios G, Karagiannis, Asterios, Mikhailidis, Dimitri I
Publicado 2012

The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings

por Athyros, Vasilios G., Gossios, Thomas D., Katsiki, Niki, Karagiannis, Asterios, Mikhailidis, Dimitri P.
Publicado 2012

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?

por Reklou, Andromachi, Doumas, Michael, Imprialos, Konstantinos, Stavropoulos, Konstantinos, Patoulias, Dimitris, Athyros, Vasilios G.
Publicado 2018

Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?

por Athyros, Vasilios G., Gossios, Thomas D., Tziomalos, Konstantinos, Florentin, Matilda, Karagiannis, Asterios, Mikhailidis, Dimitri P.
Publicado 2011

Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study

por Katsiki, Niki, Kollari, Erietta, Dardas, Sotirios, Dardas, Petros, Haidich, Anna-Bettina, Athyros, Vasilios G., Karagiannis, Asterios
Publicado 2016

Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study

por Anagnostis, Panagiotis, Adamidou, Fotini, Slavakis, Aristidis, Polyzos, Stergios A, Selalmatzidou, Despina, Panagiotou, Athanasios, Athyros, Vasilios G, Karagiannis, Asterios, Kita, Marina
Publicado 2014

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients(§)

por Athyros, Vasilios G, Kakafika, Anna I, Papageorgiou, Athanasios A, Pagourelias, Efstathios D, Savvatianos, Savvas D, Elisaf, Moses, Karagiannis, Asterios, Tziomalos, Konstantinos, Mikhailidis, Dimitri P
Publicado 2007

IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis

por Athyros, Vasilios G., Hatzitolios, Apostolos I., Karagiannis, Asterios, Savopoulos, Christos, Katsiki, Niki, Tziomalos, Konstantinos, Papagianni, Aikaterini, Kakafika, Anna, Gossios, Thomas D., Mikhailidis, Dimitri P.
Publicado 2011

Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study

por Athyros, Vasilios G., Katsiki, Niki, Tziomalos, Konstantinos, Gossios, Thomas D., Theocharidou, Eleni, Gkaliagkousi, Eygenia, Anagnostis, Panagiotis, Pagourelias, Efstathios D., Karagiannis, Asterios, Mikhailidis, Dimitri P.
Publicado 2013

Implementation of Guidelines for the Management of Arterial Hypertension. The Impulsion Study

por Karagiannis, Asterios, Hatzitolios, Apostolos I, Athyros, Vasilios G, Deligianni, Kalliopi, Charalambous, Charalambos, Papathanakis, Christos, Theodosiou, Georgios, Drakidis, Theodoros, Chatzikaloudi, Veronika, Kamilali, Chysanthi, Matsiras, Sotirios, Matziris, Athanasios, Savopoulos, Christos, Baltatzi, Maria, Rudolf, Jobst, Tziomalos, Konstantinos, Mikhailidis, Dimitri P
Publicado 2009

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

por Preiss, David, Campbell, Ross T., Murray, Heather M., Ford, Ian, Packard, Chris J., Sattar, Naveed, Rahimi, Kazem, Colhoun, Helen M., Waters, David D., LaRosa, John C., Amarenco, Pierre, Pedersen, Terje R., Tikkanen, Matti J., Koren, Michael J., Poulter, Neil R., Sever, Peter S., Ridker, Paul M., MacFadyen, Jean G., Solomon, Scott D., Davis, Barry R., Simpson, Lara M., Nakamura, Haruo, Mizuno, Kyoichi, Marfisi, Rosa M., Marchioli, Roberto, Tognoni, Gianni, Athyros, Vasilios G., Ray, Kausik K., Gotto, Antonio M., Clearfield, Michael B., Downs, John R., McMurray, John J.
Publicado 2015